Latest filing published 19 Dec 2025 for Eupraxia Pharmaceuticals Inc., €319k.
Amanda Michelle Malone is a declared insider of Eupraxia Pharmaceuticals Inc., with filings sourced from SEDI. In total, 9 filings cover trades dated from 21 September 2021 to 15 December 2025.
On the market, this insider has only ever bought: 6 purchases, €131k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants.
Half of the purchases are above €5,756 and half below. The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The newest entry dates from 19 December 2025: a share grant of €319k, in Eupraxia Pharmaceuticals Inc. The last purchase on record was published on 31 March 2023, which is 1,306 days ago. The median gap between a trade and its publication by SEDI is 1 day. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations